Mayne Pharma Commercial LLC

NC · United States · Reporting entity ID 100000136519

Total reported 2019–2025

$8.99M

#526 of 2,960 reporting companies — 0% of all reported industry payments

$7.08M in general payments across 209,187 records, plus $1.91M in research funding across 94 records.

How it breaks down

General payments $7,077,436

Research funding $1,911,011

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.